Table 1 Patient characteristics

From: Decreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancer

 

Median (range)

Age (years)

72 (45–88)

Prostate-specific antigen (ng/ml)

16.9 (4.3–316.8)

Gleason score

 ⩽6

49 (44.2%)

7

29 (27.9%)

 ⩾8

26 (25.0%)

Clinical T stage

 T⩽2

66 (63.4%)

 T⩾3

38 (36.5%)

Total

104 (100%)

Back to article page